Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print September 19, 2007
DOI: 10.2337/db07-0745

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db07-0745v1
56/12/2885    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ross, R. M.
Right arrow Articles by McConell, G. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ross, R. M.
Right arrow Articles by McConell, G. K.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Local NOS inhibition reduces skeletal muscle glucose uptake but not capillary blood flow during in situ muscle contraction in rats

Renee M. Ross, B.H.S.(Hons)1, Glenn D. Wadley, PhD2, Michael G. Clark, PhD1, Stephen Rattigan, PhD1, and Glenn K. McConell, PhD2

1 Menzies Research Institute, University of Tasmania, Hobart, Tasmania, 7001, Australia
2 Department of Physiology, The University of Melbourne, Parkville, Victoria, 3010, Australia

Objective: We have shown previously in humans that local infusion of a nitric oxide synthase (NOS) inhibitor into the femoral artery attenuates the increase in leg glucose uptake during exercise without influencing total leg blood flow. However, studies in rodents examining the effect of NOS inhibition on contraction-stimulated skeletal muscle glucose uptake have yielded contradictory results. This study examined the effect of local infusion of a NOS inhibitor on skeletal muscle glucose uptake (2-deoxyglucose) and capillary blood flow (contrast enhanced ultrasound) during in situ contractions in rats.

Research design and methods: Male hooded Wistar rats were anesthetized, then one hindleg electrically stimulated to contract (2Hz, 0.1ms) for 30 min while the other leg rested. After 10 min the NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME; arterial concentration of 5µM) or saline was infused into the epigastric artery of the contracting leg.

Results: Local NOS inhibition had no effect on blood pressure, heart rate or muscle contraction force. Contractions increased (P<0.05) skeletal muscle NOS activity and this was prevented by L-NAME infusion. NOS inhibition caused a modest significant (P<0.05) attenuation of the increase in femoral blood flow during contractions but importantly there was no effect on capillary recruitment. NOS inhibition attenuated (P<0.05) the increase in contraction-stimulated skeletal muscle glucose uptake by ~35%, without affecting AMPK activation.

Conclusions: NOS inhibition attenuated increases in skeletal muscle glucose uptake during contraction without influencing capillary recruitment suggesting that nitric oxide is critical for part of the normal increase in skeletal muscle fiber glucose uptake during contraction.


Correspondence: mcconell{at}unimelb.edu.au

Key Words: Nitric oxide • AMPK • blood flow • glucose uptake


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.